American Diabetes Association Invests in UpDoc for AI Chronic Care Platform

June 02, 2026
The American Diabetes Association’s Innovation Fund has made a strategic investment in UpDoc to advance its clinical AI platform for chronic disease management and prevention.

American Diabetes Association has made a strategic investment in UpDoc, a clinical AI company developing physician-grade agentic AI for chronic disease management. The investment was announced in a press release and comes through the ADA’s Innovation Fund, which supports technologies that improve outcomes for people living with diabetes and related conditions.

UpDoc’s platform integrates automated AI agents with clinician oversight to deliver continuous care for patients between scheduled appointments. The system aims to address clinician shortages and improve patient engagement for those managing chronic diseases such as diabetes and obesity.

The ADA said the investment will accelerate UpDoc’s efforts to scale its clinical AI tools and expand their reach. Alongside capital support, the organization will provide clinical and research expertise to guide product development and adoption.

According to the ADA, this collaboration reflects its goal of advancing practical innovations that strengthen the connection between patients and healthcare providers while expanding access to evidence-based care.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

06/02
WeInfuse and Trial IQ Partner to Integrate AI Clinical Research Tools for Infusion Providers
06/02
OpsGuru Named Launch Partner for AWS Partner Innovation Hub in Toronto
06/02
Recorded Future and Wipro Partner on AI Threat Intelligence Services
06/02
Cognizant and CrowdStrike Expand Partnership to Secure Enterprise AI
06/02
Mayo Clinic and Microsoft Develop Frontier AI Model for Healthcare

More from: Life Sciences

06/02
WeInfuse and Trial IQ Partner to Integrate AI Clinical Research Tools for Infusion Providers
06/02
Mayo Clinic and Microsoft Develop Frontier AI Model for Healthcare
06/02
Pathwork Launches Broker Access to Medical and Prescription Data
06/02
Acclinate and HCN Global Partner to Expand Clinical Research Access for Hispanic and Latino Communities
06/02
Cortechs.ai and Microsoft Integrate AI Imaging Tools into Radiology Workflows

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Governing the Future: A Strategic Framework for AI Adoption in Financial Institutions

This whitepaper explores the transformative impact of artificial intelligence on the financial industry, focusing on the governance challenges and regulatory demands faced by banks. It provides a strategic framework for AI adoption, emphasizing the importance of a unified AI approach to streamline compliance and reduce operational costs. The document offers actionable insights and expert recommendations for banks with fewer than 2,000 employees to become leaders in compliant, customer-centric AI.

Read more

You May Also Like